July 03, 2020 at 07:49AMThe Drug Controller General of India (DCGI) has granted permission to Mylan laboratories to manufacture and market the anti-viral drug remdesivir for ''restricted emergency use'' on hospitalised...
from NDTV News - India-news https://ift.tt/3gyo74L
No comments:
Post a Comment